125 related articles for article (PubMed ID: 37985159)
1. Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome.
Waddingham MT; Sequeira V; Kuster DWD; Dal Canto E; Handoko ML; de Man FS; da Silva Gonçalves Bós D; Ottenheijm CA; Shen S; van der Pijl RJ; van der Velden J; Paulus WJ; Eringa EC
Physiol Rep; 2023 Nov; 11(22):e15788. PubMed ID: 37985159
[TBL] [Abstract][Full Text] [Related]
2. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
[TBL] [Abstract][Full Text] [Related]
4. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
[TBL] [Abstract][Full Text] [Related]
5. Right-ventricular dysfunction in HFpEF is linked to altered cardiomyocyte Ca
Hegemann N; Primessnig U; Bode D; Wakula P; Beindorff N; Klopfleisch R; Michalick L; Grune J; Hohendanner F; Messroghli D; Pieske B; Kuebler WM; Heinzel FR
ESC Heart Fail; 2021 Aug; 8(4):3130-3144. PubMed ID: 34002482
[TBL] [Abstract][Full Text] [Related]
6. Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
Cuijpers I; Papageorgiou AP; Carai P; Herwig M; Mügge A; Klein T; Hamdani N; Jones EAV; Heymans S
J Cell Mol Med; 2021 Jan; 25(2):729-741. PubMed ID: 33295687
[TBL] [Abstract][Full Text] [Related]
7. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
[TBL] [Abstract][Full Text] [Related]
8. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
Leite S; Rodrigues S; Tavares-Silva M; Oliveira-Pinto J; Alaa M; Abdellatif M; Fontoura D; Falcão-Pires I; Gillebert TC; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1648-54. PubMed ID: 26408538
[TBL] [Abstract][Full Text] [Related]
9. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
[TBL] [Abstract][Full Text] [Related]
10. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
[TBL] [Abstract][Full Text] [Related]
11. Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction.
Leite S; Moreira-Costa L; Cerqueira R; Sousa-Mendes C; Angélico-Gonçalves A; Fontoura D; Vasques-Nóvoa F; Leite-Moreira AF; Lourenço AP
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):690-701. PubMed ID: 34328815
[TBL] [Abstract][Full Text] [Related]
12. Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
Primessnig U; Schönleitner P; Höll A; Pfeiffer S; Bracic T; Rau T; Kapl M; Stojakovic T; Glasnov T; Leineweber K; Wakula P; Antoons G; Pieske B; Heinzel FR
Eur J Heart Fail; 2016 Aug; 18(8):987-97. PubMed ID: 27135883
[TBL] [Abstract][Full Text] [Related]
13. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
Methawasin M; Strom JG; Slater RE; Fernandez V; Saripalli C; Granzier H
Circulation; 2016 Oct; 134(15):1085-1099. PubMed ID: 27630136
[TBL] [Abstract][Full Text] [Related]
14. In vitro model to study the effects of matrix stiffening on Ca
van Deel ED; Najafi A; Fontoura D; Valent E; Goebel M; Kardux K; Falcão-Pires I; van der Velden J
J Physiol; 2017 Jul; 595(14):4597-4610. PubMed ID: 28485491
[TBL] [Abstract][Full Text] [Related]
15. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
[TBL] [Abstract][Full Text] [Related]
16. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
[TBL] [Abstract][Full Text] [Related]
17. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
[TBL] [Abstract][Full Text] [Related]
18. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
[TBL] [Abstract][Full Text] [Related]
19. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.
Santos-Gallego CG; Requena-Ibanez JA; San Antonio R; Garcia-Ropero A; Ishikawa K; Watanabe S; Picatoste B; Vargas-Delgado AP; Flores-Umanzor EJ; Sanz J; Fuster V; Badimon JJ
JACC Cardiovasc Imaging; 2021 Feb; 14(2):393-407. PubMed ID: 33129742
[TBL] [Abstract][Full Text] [Related]
20. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]